Advertisement
Screener

VERU INC. (VERU) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

VERU INC. Operating Expenses

VERU INC. (VERU) reported Operating Expenses of $7.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-10

  • VERU INC. operating expenses for the quarter ending 2026-06-30 was $7.71M, a 3.95% decline year-over-year.
  • VERU INC. operating expenses for the quarter ending 2026-03-31 was $7.22M, a 20.64% decline year-over-year.
  • VERU INC. operating expenses for the quarter ending 2025-12-31 was $5.42M, a 50.44% decline year-over-year.
  • VERU INC. operating expenses for the quarter ending 2025-09-30 was $7.46M, a 21.79% decline year-over-year.
  • VERU INC. operating expenses for fiscal 2025 was $35.53M, a 4.98% decline from fiscal 2024.
  • VERU INC. operating expenses for fiscal 2024 was $37.39M, a 65.08% decline from fiscal 2023.
  • VERU INC. operating expenses for fiscal 2023 was $107.07M, a 6.14% decline from fiscal 2022.
  • VERU INC. operating expenses for fiscal 2022 was $114.08M, a 113.77% increase from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-06-30$7.71M
10-Q · filed 2026-08-10
$14.93M
derived: sum of 2 quarters · filed 2026-08-10
$20.36M
10-Q · filed 2026-08-10
$27.82M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$7.22M
10-Q · filed 2026-05-13
$12.64M
10-Q · filed 2026-05-13
$20.10M
derived: sum of 3 quarters · filed 2026-05-13
$28.13M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$5.42M
10-Q · filed 2026-02-11
$12.88M
derived: sum of 2 quarters · filed 2026-02-11
$20.91M
derived: sum of 3 quarters · filed 2026-08-10
$30.01M
derived: sum of 4 quarters · filed 2026-08-10
2025-09-30$7.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17
$15.49M
derived: sum of 2 quarters · filed 2026-08-10
$24.59M
derived: sum of 3 quarters · filed 2026-08-10
$35.53M
10-K · filed 2025-12-17
2025-06-30$8.03M
10-Q · filed 2026-08-10
$17.13M
derived: sum of 2 quarters · filed 2026-08-10
$28.07M
10-Q · filed 2026-08-10
$37.61M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$9.10M
10-Q · filed 2026-05-13
$20.04M
10-Q · filed 2026-05-13
$29.58M
derived: sum of 3 quarters · filed 2026-05-13
$40.23M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$10.94M
10-Q · filed 2026-02-11
$20.48M
derived: sum of 2 quarters · filed 2026-02-11
$31.14M
derived: sum of 3 quarters · filed 2026-02-11
$40.03M
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30$9.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17
$20.19M
derived: sum of 2 quarters · filed 2025-12-17
$29.08M
derived: sum of 3 quarters · filed 2025-12-17
$37.39M
10-K · filed 2025-12-17
$43.99M
10-K · filed 2024-12-16
2024-06-30$10.66M
10-Q · filed 2025-08-12
$12.39M
10-Q · filed 2024-08-08
$19.54M
derived: sum of 2 quarters · filed 2025-08-12
$27.85M
10-Q · filed 2025-08-12
$32.91M
10-Q · filed 2024-08-08
$38.57M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$8.89M
10-Q · filed 2025-05-08
$10.57M
10-Q · filed 2024-05-08
$17.20M
10-Q · filed 2025-05-08
$20.52M
10-Q · filed 2024-05-08
$27.92M
derived: sum of 3 quarters · filed 2025-05-08
$47.61M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$8.31M
10-Q · filed 2025-02-13
$9.95M
10-Q · filed 2024-04-01
$19.03M
derived: sum of 2 quarters · filed 2025-02-13
$38.72M
derived: sum of 3 quarters · filed 2025-02-13
$77.22M
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30$10.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16
$30.41M
derived: sum of 2 quarters · filed 2024-12-16
$68.91M
derived: sum of 3 quarters · filed 2024-12-16
$107.07M
10-K · filed 2024-12-16
$107.01M
10-K · filed 2023-12-08
2023-06-30$19.69M
10-Q · filed 2024-08-08
$13.83M
10-Q · filed 2023-08-10
$58.20M
derived: sum of 2 quarters · filed 2024-08-08
$96.35M
10-Q · filed 2024-08-08
$93.63M
10-Q · filed 2023-08-10
$141.80M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$38.51M
10-Q · filed 2024-05-08
$43.51M
10-Q · filed 2023-05-11
$76.66M
10-Q · filed 2024-05-08
$79.80M
10-Q · filed 2023-05-11
$122.11M
derived: sum of 3 quarters · filed 2024-05-08
$151.00M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$38.16M
10-K/A · filed 2024-04-01
$36.29M
10-Q · filed 2023-02-09
$83.60M
derived: sum of 2 quarters · filed 2024-04-01
$112.49M
derived: sum of 3 quarters · filed 2024-04-01
$135.43M
derived: sum of 4 quarters · filed 2024-04-01
2022-09-30$45.44M
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01
$74.33M
derived: sum of 2 quarters · filed 2024-04-01
$97.28M
derived: sum of 3 quarters · filed 2024-04-01
$114.08M
10-K/A · filed 2024-04-01
$113.81M
10-K · filed 2022-12-05
2022-06-30$28.89M
10-Q/A · filed 2023-11-15
$51.83M
derived: sum of 2 quarters · filed 2023-11-15
$68.64M
10-Q/A · filed 2023-11-15
$82.82M
derived: sum of 4 quarters · filed 2023-11-15
2022-03-31$22.94M
10-Q · filed 2023-05-11
$39.74M
10-Q · filed 2023-05-11
$53.93M
derived: sum of 3 quarters · filed 2023-05-11
$70.67M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$16.80M
10-Q · filed 2023-02-09
$30.98M
derived: sum of 2 quarters · filed 2023-02-09
$47.73M
derived: sum of 3 quarters · filed 2023-02-09
$60.11M
derived: sum of 4 quarters · filed 2023-02-09
2021-09-30$14.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05
$30.93M
derived: sum of 2 quarters · filed 2022-12-05
$43.31M
derived: sum of 3 quarters · filed 2022-12-05
$53.36M
10-K · filed 2022-12-05
2021-06-30$16.74M
10-Q · filed 2022-08-11
$29.12M
derived: sum of 2 quarters · filed 2022-08-11
$39.18M
10-Q · filed 2022-08-11
$45.92M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$12.38M
10-Q · filed 2022-05-12
$22.44M
10-Q · filed 2022-05-12
$29.17M
derived: sum of 3 quarters · filed 2022-05-12
$37.08M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$10.06M
10-Q · filed 2022-02-09
$16.79M
derived: sum of 2 quarters · filed 2022-02-09
$24.70M
derived: sum of 3 quarters · filed 2022-02-09
$32.44M
derived: sum of 4 quarters · filed 2022-02-09
2020-09-30$6.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02
$14.64M
derived: sum of 2 quarters · filed 2021-12-02
$22.38M
derived: sum of 3 quarters · filed 2021-12-02
$31.43M
10-K · filed 2021-12-02
$45.53M
10-K · filed 2020-12-10
2020-06-30$7.91M
10-Q · filed 2021-08-12
$15.65M
derived: sum of 2 quarters · filed 2021-08-12
$24.70M
10-Q · filed 2021-08-12
$31.99M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$7.74M
10-Q · filed 2021-05-12
$16.79M
10-Q · filed 2021-05-12
$24.08M
derived: sum of 3 quarters · filed 2021-05-12
$32.49M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$9.05M
10-Q · filed 2021-02-10
$16.34M
derived: sum of 2 quarters · filed 2021-02-10
$24.76M
derived: sum of 3 quarters · filed 2021-02-10
$31.49M
derived: sum of 4 quarters · filed 2021-02-10
2019-09-30$7.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10
$15.70M
derived: sum of 2 quarters · filed 2020-12-10
$22.44M
derived: sum of 3 quarters · filed 2020-12-10
$28.09M
10-K · filed 2020-12-10
2019-06-30$8.41M
10-Q · filed 2020-08-13
$15.15M
derived: sum of 2 quarters · filed 2020-08-13
$20.80M
10-Q · filed 2020-08-13
$27.76M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$6.73M
10-Q · filed 2020-05-13
$12.39M
10-Q · filed 2020-05-13
$19.35M
derived: sum of 3 quarters · filed 2020-05-13
$27.39M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31$5.66M
10-Q · filed 2020-02-12
$12.62M
derived: sum of 2 quarters · filed 2020-02-12
$20.66M
derived: sum of 3 quarters · filed 2020-02-12
$26.55M
derived: sum of 4 quarters · filed 2020-02-12
2018-09-30$6.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12
$15.00M
derived: sum of 2 quarters · filed 2019-12-12
$20.89M
derived: sum of 3 quarters · filed 2019-12-12
$29.64M
10-K · filed 2019-12-12
$29.65M
10-K · filed 2018-12-13
2018-06-30$8.04M
10-Q · filed 2019-08-08
$8.04M
10-Q · filed 2018-08-14
$13.93M
derived: sum of 2 quarters · filed 2019-08-08
$22.68M
10-Q · filed 2019-08-08
$22.69M
10-Q · filed 2018-08-14
$27.25M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$5.89M
10-Q · filed 2019-05-15
$5.90M
10-Q · filed 2018-05-11
$14.64M
10-Q · filed 2019-05-15
$14.65M
10-Q · filed 2018-05-11
$19.21M
derived: sum of 3 quarters · filed 2019-05-15
$22.77M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$8.75M
10-Q · filed 2019-02-13
$8.75M
10-Q · filed 2018-02-14
$13.32M
derived: sum of 2 quarters · filed 2019-02-13
$16.88M
derived: sum of 3 quarters · filed 2019-02-13
$20.74M
derived: sum of 4 quarters · filed 2019-02-13
2017-09-30$4.57M
10-K · filed 2018-01-02
$8.13M
derived: sum of 2 quarters · filed 2018-08-14
$11.99M
derived: sum of 3 quarters · filed 2018-08-14
$15.51M
10-K · filed 2018-12-13
2017-06-30$3.56M
10-Q · filed 2018-08-14
$7.42M
derived: sum of 2 quarters · filed 2018-08-14
$10.94M
10-Q · filed 2018-08-14
$13.11M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$3.86M
10-Q · filed 2018-05-11
$7.38M
10-Q · filed 2018-05-11
$9.55M
derived: sum of 3 quarters · filed 2018-05-11
$11.93M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31$3.53M
10-Q · filed 2018-02-14
$5.69M
derived: sum of 2 quarters · filed 2018-02-14
$8.07M
derived: sum of 3 quarters · filed 2018-02-14
$10.85M
derived: sum of 4 quarters · filed 2018-02-14
2016-09-30$2.16M
10-K · filed 2018-01-02
$4.55M
derived: sum of 2 quarters · filed 2018-01-02
$7.32M
derived: sum of 3 quarters · filed 2018-01-02
$10.33M
10-K · filed 2018-01-02
2016-06-30$2.38M
10-K · filed 2018-01-02
$5.16M
derived: sum of 2 quarters · filed 2018-01-02
$8.17M
10-Q · filed 2017-08-09
$11.53M
derived: sum of 4 quarters · filed 2018-01-02
2016-03-31$2.77M
10-K · filed 2018-01-02
$5.78M
10-Q · filed 2017-05-10
$9.15M
derived: sum of 3 quarters · filed 2018-01-02
$12.33M
derived: sum of 4 quarters · filed 2018-01-02
2015-12-31$3.01M
10-K · filed 2018-01-02
$6.37M
derived: sum of 2 quarters · filed 2018-01-02
$9.55M
derived: sum of 3 quarters · filed 2018-01-02
$13.00M
derived: sum of 4 quarters · filed 2018-01-02
2015-09-30$3.36M
10-K · filed 2016-12-12
$6.54M
derived: sum of 2 quarters · filed 2016-12-12
$9.99M
derived: sum of 3 quarters · filed 2016-12-12
$12.35M
10-K · filed 2018-01-02
2015-06-30$3.18M
10-K · filed 2016-12-12
$6.62M
derived: sum of 2 quarters · filed 2016-12-12
$8.99M
10-Q · filed 2016-07-28
$12.36M
derived: sum of 4 quarters · filed 2016-12-12
2015-03-31$3.44M
10-K · filed 2016-12-12
$5.81M
10-Q · filed 2016-04-28
$9.18M
derived: sum of 3 quarters · filed 2016-12-12
$11.32M
derived: sum of 4 quarters · filed 2016-12-12
2014-12-31$2.37M
10-K · filed 2016-12-12
$5.74M
derived: sum of 2 quarters · filed 2016-12-12
$7.88M
derived: sum of 3 quarters · filed 2016-12-12
$9.47M
derived: sum of 4 quarters · filed 2016-12-12
2014-09-30$3.37M
10-K · filed 2015-12-02
$5.51M
derived: sum of 2 quarters · filed 2015-12-02
$7.10M
derived: sum of 3 quarters · filed 2015-12-02
$9.20M
10-K · filed 2016-12-12
2014-06-30$2.14M
10-K · filed 2015-12-02
$3.73M
derived: sum of 2 quarters · filed 2015-12-02
$5.83M
10-Q · filed 2015-07-30
$6.36M
derived: sum of 4 quarters · filed 2015-12-02
2014-03-31$1.59M
10-K · filed 2015-12-02
$3.69M
10-Q · filed 2015-04-30
$4.22M
derived: sum of 3 quarters · filed 2015-12-02
$6.87M
derived: sum of 4 quarters · filed 2015-12-02
2013-12-31$2.09M
10-K · filed 2015-12-02
$2.63M
derived: sum of 2 quarters · filed 2015-12-02
$5.28M
derived: sum of 3 quarters · filed 2015-12-02
$7.44M
derived: sum of 4 quarters · filed 2015-12-02
2013-09-30$532.98K
10-K · filed 2014-12-02
$3.19M
derived: sum of 2 quarters · filed 2014-12-02
$5.35M
derived: sum of 3 quarters · filed 2014-12-02
$7.71M
10-K · filed 2015-12-02
2013-06-30$2.65M
10-K · filed 2014-12-02
$4.82M
derived: sum of 2 quarters · filed 2014-12-02
$7.18M
10-Q · filed 2014-07-31
$9.75M
derived: sum of 4 quarters · filed 2014-12-02
2013-03-31$2.16M
10-K · filed 2014-12-02
$4.53M
10-Q · filed 2014-05-01
$7.09M
derived: sum of 3 quarters · filed 2014-12-02
$9.58M
derived: sum of 4 quarters · filed 2014-12-02
2012-12-31$2.37M
10-K · filed 2014-12-02
$4.93M
derived: sum of 2 quarters · filed 2014-12-02
$7.42M
derived: sum of 3 quarters · filed 2014-12-02
$9.81M
derived: sum of 4 quarters · filed 2014-12-02
2012-09-30$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02
$5.05M
derived: sum of 2 quarters · filed 2014-12-02
$7.45M
derived: sum of 3 quarters · filed 2014-12-02
$9.68M
10-K · filed 2014-12-02
2012-06-30$2.49M
10-Q · filed 2013-08-01
$4.88M
derived: sum of 2 quarters · filed 2013-08-01
$7.12M
10-Q · filed 2013-08-01
$9.03M
derived: sum of 4 quarters · filed 2013-12-03
2012-03-31$2.40M
10-Q · filed 2013-05-02
$4.63M
10-Q · filed 2013-05-02
$6.55M
derived: sum of 3 quarters · filed 2013-12-03
$7.91M
derived: sum of 4 quarters · filed 2013-12-03
2011-12-31$2.23M
10-Q · filed 2013-01-30
$4.15M
derived: sum of 2 quarters · filed 2013-12-03
$5.51M
derived: sum of 3 quarters · filed 2013-12-03
2011-09-30$1.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03
$3.28M
derived: sum of 2 quarters · filed 2013-12-03
$6.57M
10-K · filed 2013-12-03
2011-06-30$1.36M
10-Q · filed 2012-07-31
$4.65M
10-Q · filed 2012-07-31
2010-09-30$1.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04
$2.46M
derived: sum of 2 quarters · filed 2012-12-04
$8.58M
10-K · filed 2012-12-04
2010-06-30$918.40K
10-Q · filed 2011-08-05
$7.03M
10-Q · filed 2011-08-05
2009-09-30$8.80M
10-K · filed 2011-12-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34